claRx Big Country Dermatology Pharmacy prioritizes provider relationships. We utilize a pharmacy liason to build trusting relationships between us and the dermatology clinics. Our purpose is to make a positive difference in people's lives and the best way to do that is by seeing people for whom they are and developing relationships.
A patient waiting a week for a medication change is unacceptable. We can make a positive impact here.
Provider protocols are not new to the world of medicine. Physicians have been using them for years in hospitals in order to allow a more team centered approach between providers and pharmacists. This team approach gives patients better care and lower costs.
Our proven process has been honed over years of experience. And like all great processes, it was born out of a higher cause. Our team knows what our purpose is, we believe in affordable access to dermatology medications. And because each one of our team members comes to work every day with that belief, we are able to create processes and find ways to provide that service to our patients.
As knowledge increases worldwide, we are advancing every day in every field. Over the years, the field of pharmacy has continued to make the existence of man a better one through the regulation of drugs.
Simply defined, iPledge is a patient safety program for patients on or intending to take isotretinoin and it is designed to prevent harm from coming to unborn children of pregnant women, as well as other potential harmful side effects if not monitored by your provider. In technical terms, it is a REMS (Risk Evaluation and Mitigation Strategy) program implemented through the FDA.
Compounding refers to the process of customizing medications by a professional pharmacist to address the specific needs of an individual patient. This is especially helpful when commercially available medications contain an unwanted inactive ingredient, or are not easy to find, not effective, or not available. It is an encompassing process, allowing pharmacists to alter, combine, or mix various ingredients to create medications not available by manufacturers.
The rising cost of mediations in dermatology has not stopped to be a source of worry over the years. It can be described as a disastrous development, and it does not look to stop anytime soon. The costs have increased dramatically in multiple folds over the years, which honestly is an outrageous situation. As a result of this, patients that are suffering from significant skin disorders that can be easily treated often go without therapy just for financial reasons. This also affects the pharmacists and dermatologists that are taking care of these patients.